| Predicted Trait | |
| Reported Trait | Oropharynx cancer |
| Mapped Trait(s) | oropharynx cancer (MONDO_0004608) |
| Score Construction | |
| PGS Name | PRS_HNC_OPC |
| Development Method | |
| Name | PRS-CS |
| Parameters | NR |
| Variants | |
| Original Genome Build | NR |
| Number of Variants | 972,182 |
| Effect Weight Type | beta |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000822 |
| Citation (link to publication) | Lee YC et al. BMC Med (2024) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 6,629 individuals (100%) |
| PGS Evaluation | |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
Europe PMC: 27749845 |
[
|
European | EPIC, HN5000, INHANCE |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM030761 | PSS012283| Multi-ancestry (including European)| 37,901 individuals |
PGP000822 | Lee YC et al. BMC Med (2024) |
Reported Trait: Oropharynx cancer | OR: 1.24 [1.08, 1.42] | — | — | age, sex, ethnicity, and PC 1 to 10 | — |
| PPM030757 | PSS012284| European Ancestry| 307,295 individuals |
PGP000822 | Lee YC et al. BMC Med (2024) |
Reported Trait: Oropharynx cancer | OR: 1.09 [1.02, 1.17] | — | — | age, sex, genotype array, and PC 1 to 10 | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS012283 | — | — | [
|
— | European, African American or Afro-Caribbean | — | PMB | — |
| PSS012284 | — | — | [
|
— | European | — | UKB | — |